Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care.

Martín-Pérez, Mar; Ruigómez, Ana; Michel, Alexander; García Rodríguez, Luis A

Martín-Pérez, Mar; Ruigómez, Ana; Michel, Alexander; García Rodríguez, Luis A.

Affiliation

Martín-Pérez M; Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain.
Ruigómez A; Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain.
Michel A; Epidemiology, Bayer Pharma AG, 13342, Berlin, Germany. alexander.michel@bayer.com.
García Rodríguez LA; Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain.

BMC Fam Pract ; 17: 51, 2016 05 04.

Article in En | MEDLINE | ID: mdl-27145981

Subject(s)

Heart Failure/diagnosis; Hyperkalemia/diagnosis; Hyperkalemia/epidemiology; Potassium/blood; Primary Health Care; Adult; Aged; Aged, 80 and over; Female; Humans; Hyperkalemia/blood; Hyperkalemia/mortality; Incidence; Male; Middle Aged; Reference Values; Retrospective Studies; United Kingdom/epidemiology; Young Adult

Key words

Cohort study; Heart failure; Hyperkalaemia; Incidence; Primary care

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Potassium / Primary Health Care / Heart Failure / Hyperkalemia Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google